Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
93.901,50
-0,71%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Compugen Ltd (CGEN) Compugen Ltd (CGEN) Notizie

Compugen Ltd

CGEN
1,64
0,05 (3,14%)
11 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/1/202513:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202513:00PRNUSCompugen Announces First Patient Dosed in Phase 1 Clinical..
27/11/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/11/202413:00PRNUSCompugen Expands its Intellectual Property Portfolio with..
12/11/202413:00PRNUSCompugen Reports Third Quarter 2024 Results
11/11/202413:00PRNUSCompugen to Participate in Stifel 2024 Healthcare Conference
05/11/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/11/202415:00PRNUSCompugen to Present Anti-Tumor Activity and Safety Data of..
29/10/202412:00PRNUSCompugen to Release Third Quarter 2024 Financial Results on..
07/10/202413:00PRNUSCompugen to Present New Clinical Data at SITC 2024
13/9/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/9/202413:00PRNUSCompugen to Present at Single Cell Genomics 2024 Conference
29/8/202413:00PRNUSCompugen to Present at the H.C. Wainwright 26th Annual..
06/8/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/8/202413:00PRNUSCompugen Reports Second Quarter 2024 Results
05/8/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/7/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/7/202413:00PRNUSCompugen Announces FDA Clearance of IND for COM503 for the..
23/7/202413:00PRNUSCompugen to Release Second Quarter 2024 Results on Tuesday,..
17/6/202413:00PRNUSCompugen to Present at Upcoming Antibody Industrial..
30/5/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/5/202413:00PRNUSCompugen to Receive Milestone Payment Triggered by Dosing of..
20/5/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/5/202413:00PRNUSCompugen Reports First Quarter 2024 Results
20/5/202412:59IHMARKETNEWSU.S. Index Futures Edge Slightly Higher in Pre-Market..
16/5/202413:00PRNUSCompugen Publishes Paper in Cancer Immunology Research on..
15/5/202413:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/5/202413:00PRNUSCompugen Appoints David Silberman as Chief Financial Officer
06/5/202413:00PRNUSCompugen to Release First Quarter 2024 Results on Monday,..
25/4/202413:00PRNUSCompugen to Present New Clinical Data Showing COM701 Triple..
10/4/202413:00PRNUSCompugen Publishes Paper in Cancer Immunology Research..
03/4/202413:00PRNUSCompugen to Participate in Two Upcoming Investor Conferences
11/3/202412:00PRNUSCompugen Selected for two Oral Presentations at the Keystone..
06/3/202413:00PRNUSCompugen to Present Data Reflecting its Diversified..
05/3/202422:06EDGAR2Form 20-F - Annual and transition report of foreign private..
05/3/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/3/202413:00PRNUSCompugen Reports Fourth Quarter and Full Year 2023 Results
05/3/202412:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
26/2/202413:00PRNUSCompugen to Present at the Leerink Partners Global Biopharma..
20/2/202413:00PRNUSCompugen to Release Fourth Quarter and Full Year 2023..
15/2/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202413:00PRNUSCompugen Announces Appointment of Michelle Mahler M.D. as..
Apertura: 1,59 Min: 1,56 Max: 1,72
Chiusura: 1,59

La tua Cronologia

NASDAQ
CGEN
Compugen
EU
BPCGD
BPCE Bpcefrn09jun28
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network